IRT5益生菌调节自身免疫性干眼小鼠眶外泪腺免疫调节蛋白表达
该研究在NOD.B10.H2b自身免疫性干眼小鼠模型中,口服IRT5益生菌(五种菌株混合物)或PBS三周,伴或不伴五天抗生素预处理,分析临床特征、眶外泪腺与脾脏蛋白及粪便微生物群。结果显示IRT5组眼表染色评分更低、泪液分泌更高,泪腺中防御反应和免疫系统过程相关蛋白下调,粪便33个OTU相对丰度升高、53个降低,脾脏CD11b+和CD11c+细胞中抗原呈递相关蛋白减少。结论认为IRT5通过下调免疫网络中的抗原呈递过程改善临床表现。
要点
- IRT5益生菌口服可降低自身免疫性干眼小鼠眼表染色评分并增加泪液分泌。
- IRT5处理下调泪腺中防御反应和免疫系统过程相关蛋白,并减少脾脏CD11b+和CD11c+细胞抗原呈递蛋白。
- IRT5改变粪便微生物群,33个OTU相对丰度升高、53个降低,且不依赖抗生素预处理仍显示免疫调节功能。
核心结论
- IRT5治疗后的肠道微生物群变化通过下调免疫网络中的抗原呈递过程改善自身免疫性干眼模型的临床表现。
研究设计与样本
- 使用NOD.B10.H2b小鼠作为自身免疫性干眼模型,口服灌胃IRT5或PBS三周,伴或不伴五天抗生素预处理。
- 分析临床特征、眶外泪腺和脾脏蛋白以及粪便微生物群。
主要发现
- IRT5治疗组眼表染色评分低于PBS组,泪液分泌高于PBS组。
- IRT5治疗后泪腺中下调的蛋白富集于防御反应和免疫系统过程。
- IRT5治疗组粪便中33个OTU相对丰度高于PBS组,53个低于PBS组。
- 无抗生素预处理的IRT5给药也显示免疫调节功能,伴随Lactobacillus helveticus组和Lactobacillus hamsteri增加。
- IRT5治疗组脾脏CD11b+和CD11c+细胞中抗原呈递相关蛋白减少。
临床怎么用
- 提示IRT5益生菌可能通过调节肠道微生物群和抗原呈递过程改善自身免疫性干眼,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While the association between the gut microbiome and the immune system has been studied in autoimmune disorders, little is known about ocular disease. Previously we reported that IRT5, a mixture of five probiotic strains, could suppress autoimmune dry eye. In this study, we investigated the mechanism by which IRT5 performs its immunomodulatory function in a mouse model of autoimmune dry eye. METHODS: NOD.B10.H2b mice were used as an autoimmune dry eye model. Either IRT5 or PBS was gavaged orally for 3 weeks, with or without 5 days of antibiotic pretreatment. The effects on clinical features, extraorbital lacrimal gland and spleen proteins, and fecal microbiota were analyzed. RESULTS: The ocular staining score was lower, and tear secretion was higher, in the IRT5-treated groups than in the PBS-treated groups. After IRT5 treatment, the downregulated lacrimal gland proteins were enriched in the biological processes of defense response and immune system process. The relative abundances of 33 operational taxonomic units were higher, and 53 were lower, in the feces of the IRT5-treated groups than in those of the PBS-treated groups. IRT5 administration without antibiotic pretreatment also showed immunomodulatory functions with increases in the Lactobacillus helveticus group and Lactobacillus hamsteri. Additional proteomic assays revealed a decrease of proteins related to antigen-presenting processes in the CD11b+ and CD11c+ cells of spleen in the IRT5-treated groups. CONCLUSIONS: Changes in the gut microbiome after IRT5 treatment improved clinical manifestations in the autoimmune dry eye model via the downregulation of antigen-presenting processes in immune networks.
引用
- Choi SH, Oh JW, Ryu JS, et al. IRT5 Probiotics Changes Immune Modulatory Protein Expression in the Extraorbital Lacrimal Glands of an Autoimmune Dry Eye Mouse Model. Invest Ophthalmol Vis Sci. 2020. PMID: 32232342. doi:10.1167/iovs.61.3.42
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。